99 related articles for article (PubMed ID: 27289182)
1. Loss of endothelial barrier integrity in mice with conditional ablation of podocalyxin (Podxl) in endothelial cells.
Horrillo A; Porras G; Ayuso MS; González-Manchón C
Eur J Cell Biol; 2016 Aug; 95(8):265-76. PubMed ID: 27289182
[TBL] [Abstract][Full Text] [Related]
2. Podocalyxin regulates murine lung vascular permeability by altering endothelial cell adhesion.
Debruin EJ; Hughes MR; Sina C; Lu A; Cait J; Jian Z; Lopez M; Lo B; Abraham T; McNagny KM
PLoS One; 2014; 9(10):e108881. PubMed ID: 25303643
[TBL] [Abstract][Full Text] [Related]
3. Podocalyxin is required for maintaining blood-brain barrier function during acute inflammation.
Cait J; Hughes MR; Zeglinski MR; Chan AW; Osterhof S; Scott RW; Canals Hernaez D; Cait A; Vogl AW; Bernatchez P; Underhill TM; Granville DJ; Murphy TH; Roskelley CD; McNagny KM
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4518-4527. PubMed ID: 30787191
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte-endothelial cell interaction is enhanced in podocalyxin-deficient mice.
Porras G; Ayuso MS; González-Manchón C
Int J Biochem Cell Biol; 2018 Jun; 99():72-79. PubMed ID: 29604348
[TBL] [Abstract][Full Text] [Related]
5. Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin.
Doyonnas R; Kershaw DB; Duhme C; Merkens H; Chelliah S; Graf T; McNagny KM
J Exp Med; 2001 Jul; 194(1):13-27. PubMed ID: 11435469
[TBL] [Abstract][Full Text] [Related]
6. Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells.
Larrucea S; Butta N; Arias-Salgado EG; Alonso-Martin S; Ayuso MS; Parrilla R
Exp Cell Res; 2008 Jun; 314(10):2004-15. PubMed ID: 18456258
[TBL] [Abstract][Full Text] [Related]
7. Increased endothelial cell permeability in endoglin-deficient cells.
Jerkic M; Letarte M
FASEB J; 2015 Sep; 29(9):3678-88. PubMed ID: 25972355
[TBL] [Abstract][Full Text] [Related]
8. Ventricular enlargement associated with the panneural ablation of the podocalyxin gene.
Nowakowski A; Alonso-Martín S; González-Manchón C; Larrucea S; Fernández D; Vilar M; Cerdán S; Ayuso MS; Parrilla R
Mol Cell Neurosci; 2010 Jan; 43(1):90-7. PubMed ID: 19837166
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
[TBL] [Abstract][Full Text] [Related]
10. A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts.
Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Kato Y
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203331
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat.
Testa JE; Chrastina A; Li Y; Oh P; Schnitzer JE
J Vasc Res; 2009; 46(4):311-24. PubMed ID: 19142011
[TBL] [Abstract][Full Text] [Related]
12. PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.
Ogasawara S; Kaneko MK; Yamada S; Honma R; Nakamura T; Saidoh N; Yanaka M; Yoshida K; Fujii Y; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Apr; 36(2):50-56. PubMed ID: 28384052
[TBL] [Abstract][Full Text] [Related]
13. PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin.
Canals Hernaez D; Hughes MR; Dean P; Bergqvist P; Samudio I; Blixt O; Wiedemeyer K; Li Y; Bond C; Cruz E; Köbel M; Gilks B; Roskelley CD; McNagny KM
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33243933
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial cadherin expression in lung specimens of patients with sepsis-induced acute respiratory distress syndrome and endothelial cell cultures.
Herwig MC; Tsokos M; Hermanns MI; Kirkpatrick CJ; Müller AM
Pathobiology; 2013; 80(5):245-51. PubMed ID: 23635392
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of podocalyxin in megakaryocytes and platelets decreases the bleeding time and enhances the agonist-induced aggregation of platelets.
Alonso-Martin S; Nowakowski A; Larrucea S; Fernández D; Vilar-Egea M; Ayuso MS; Parrilla R
Thromb Res; 2010 Jun; 125(6):e300-5. PubMed ID: 20223501
[TBL] [Abstract][Full Text] [Related]
16. Release of podocalyxin into the extracellular space. Role of metalloproteinases.
Fernández D; Larrucea S; Nowakowski A; Pericacho M; Parrilla R; Ayuso MS
Biochim Biophys Acta; 2011 Aug; 1813(8):1504-10. PubMed ID: 21616097
[TBL] [Abstract][Full Text] [Related]
17. A novel approach to prevent endothelial hyperpermeability: the Crataegus extract WS® 1442 targets the cAMP/Rap1 pathway.
Bubik MF; Willer EA; Bihari P; Jürgenliemk G; Ammer H; Krombach F; Zahler S; Vollmar AM; Fürst R
J Mol Cell Cardiol; 2012 Jan; 52(1):196-205. PubMed ID: 22085704
[TBL] [Abstract][Full Text] [Related]
18. Multiple-site activation of the cysteinyl leukotriene receptor 2 is required for exacerbation of ischemia/reperfusion injury.
Ni NC; Ballantyne LL; Mewburn JD; Funk CD
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):321-30. PubMed ID: 24285579
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.
Singleton PA; Moreno-Vinasco L; Sammani S; Wanderling SL; Moss J; Garcia JG
Am J Respir Cell Mol Biol; 2007 Aug; 37(2):222-31. PubMed ID: 17395891
[TBL] [Abstract][Full Text] [Related]
20. RhoGDI-1 modulation of the activity of monomeric RhoGTPase RhoA regulates endothelial barrier function in mouse lungs.
Gorovoy M; Neamu R; Niu J; Vogel S; Predescu D; Miyoshi J; Takai Y; Kini V; Mehta D; Malik AB; Voyno-Yasenetskaya T
Circ Res; 2007 Jul; 101(1):50-8. PubMed ID: 17525371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
